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ABSTRACT 34 
High energy trauma to cartilage causes surface fissures and microstructural damage, but 35 
the degree to which this damage renders the tissue more susceptible to wear and contributes to 36 
the progression of post-traumatic osteoarthritis (PTOA) is unknown.  Additionally, no treatments 37 
are currently available to strengthen cartilage after joint trauma and to protect the tissue from 38 
subsequent degradation and wear.  The purposes of this study were to investigate the role of 39 
mechanical damage in the degradation and wear of cartilage, to evaluate the effects of impact 40 
and subsequent genipin crosslinking on the changes in the viscoelastic parameters of articular 41 
cartilage, and to test the hypothesis that genipin crosslinking is an effective treatment to enhance 42 
the resistance to biochemical degradation and mechanical wear.  Results demonstrate that 43 
cartilage stiffness decreases after impact loading, likely due to the formation of fissures and 44 
microarchitectural damage, and is partially or fully restored by crosslinking.  The wear resistance 45 
of impacted articular cartilage was diminished compared to undamaged cartilage, suggesting that 46 
mechanical damage that is directly induced by the impact may contribute to the progression of 47 
PTOA.  However, the decrease in wear resistance was completely reversed by the crosslinking 48 
treatments.  Additionally, the crosslinking treatments improved the resistance to collagenase 49 
digestion at the impact-damaged articular surface.  These results highlight the potential 50 
therapeutic value of collagen crosslinking via genipin in the prevention of cartilage degeneration 51 
after traumatic injury. 52 
 53 
 54 
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INTRODUCTION 57 
Of the estimated 21 million Americans that suffer from osteoarthritis (OA), 58 
approximately 12% of those cases are traumatic in origin.1,2  High energy trauma to a synovial 59 
joint causes an array of mechanical, cellular, and biochemical responses that can ultimately lead 60 
to posttraumatic osteoarthritis (PTOA).  A single traumatic event can result in an increased 61 
expression of pro-inflammatory cytokines that are thought to activate degradative enzymes in the 62 
cartilage and lead to reduced mechanical properties and ultimately wear resistance.3–6  63 
Additionally, mechanical cracks or fissures have been observed at the injury sites on the cartilage 64 
surface immediately following trauma, extending down at approximately a 45 degree angle into 65 
superficial, middle, or deep zones.3,7–13  Even without evidence of fissures, microstructural 66 
damage can occur at the articular surface at the site of injury.14  In spite of the prevalence of this 67 
acute damage after a traumatic overload to the joint, its effect on mechanical wear of cartilage 68 
and the development of PTOA is unknown.   69 
PTOA often progresses to the point where the joint needs to be replaced, and total joint 70 
replacements are widely successful procedures.  However, PTOA affects many younger 71 
individuals for whom arthroplasty is a poor option due to the limited lifespan of the implants.15–17  72 
Current surgical treatments at the time of injury, such as anatomic reduction of intra-articular 73 
fractures, ligament repair, joint stabilization, and osteotomies, treat intra-articular fractures or 74 
improve joint instability or incongruity,2,18–22 but do not address the mechanical damage to the 75 
articular surface or intervene in the post-traumatic cellular response.  Recent studies have 76 
demonstrated that biological therapies can limit chondrocyte damage caused by a mechanical 77 
overload and impair the subsequent activation of catabolic pathways.  For example, D’Lima et 78 
al. demonstrated that a caspase inhibitor reduces chondrocyte aptoposis23 while Haut and 79 
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coworkers have shown that a surfactant decreases cellular necrosis after a mechanical insult to 80 
cartilage tissue.24,25  Martin et al. have reported that antioxidants are effective at reducing 81 
chondrocyte death and concomitant matrix degradation.26–28  Ding et al. investigated another 82 
biological target, mitogen activated protein kinases, which can be inhibited to reduce injury-83 
related chondrocyte death and proteoglycan loss.29     In spite of the promise of these biologic 84 
treatments, they do not address the mechanical damage at the articular surface, or restore the 85 
mechanical integrity of the tissue.   86 
Our previous work investigated collagen crosslinking of cartilage using genipin, a natural 87 
plant extract, as a potential therapeutic treatment.  Both 2 mM and 10 mM genipin crosslinking 88 
treatments improved the wear resistance of healthy, intact cartilage in vitro.  These treatments 89 
increased the stiffness via indentation and significantly protected the tissue from collagenase 90 
digestion.  The 2 mM genipin treatment was non-toxic to chondrocytes, indicating its potential as 91 
a clinical treatment to prevent osteoarthritis.30  However, the effect of crosslinking on cartilage 92 
that has been damaged by a traumatic overload has not been investigated.  The goal of this study 93 
was to investigate the effect of mechanical damage and genipin crosslinking on cartilage’s 94 
viscoelastic parameters, wear resistance, coefficient of friction and biochemical enzymatic 95 
degradation.  96 
METHODS 97 
IMPACT DAMAGE 98 
Bovine stifles from approximately 1-year old animals were obtained from a local abattoir 99 
(Martins Meats, Wakarusa, IN) and were stored frozen at -23 °C until use.  Osteochondral 100 
specimens with a 9.5 mm diameter and approximately 25 mm in length were cored from the 101 
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condyles such that the articular surface was perpendicular to the coring axis, with no more than 102 
two specimens taken per condyle.  The specimens were placed with the articular surface facing 103 
upwards into the loading chamber of a custom designed drop tower, which was similar to 104 
previously reported devices (Figure S1).31–33  Preliminary testing determined that cartilage was 105 
visually damaged in unconfined compression using a spherical impact head that was 3.2 cm in 106 
diameter, dropped from a height of 25 cm with a total impactor mass of 499 g.    Specimens that 107 
resulted in bone fracture or delamination of the cartilage from the bone were discarded.  The 108 
drop tower was instrumented with an accelerometer (Kistler 8743A5; Novi, MI) and a load cell 109 
(Kistler 9712B5000) for the collection of impact data at 100 kHz (n = 8).  The accelerometer 110 
data was integrated twice with respect to time to determine the velocity and displacement using a 111 
custom Matlab script.  The maximum and average contact pressures at peak impact were 112 
calculated from the load and displacement data using Hertz contact theory.34 The impact energy 113 
was evaluated by integrating the load with respect to displacement.  Average strain through the 114 
depth of the tissue was calculated by dividing the tissue displacement by thickness, and the 115 
average strain rate was calculated from the maximum average strain divided by the time duration 116 
of the impact to that point.  A range of strains and strain rates were calculated for cartilage 117 
thicknesses from 1.2 to 1.5 mm, based on our previous observation that 8 to10 sections of 150 118 
µm thickness can be taken through the depth of our samples.   119 
 120 
GENIPIN CROSSLINKING 121 
Following impact, cartilage specimens were incubated in 0, 2, or 10 mM genipin 122 
(Challenge Bioproducts, Taiwan) solutions in phosphate-buffered saline (PBS) at 37 ºC for 15 123 
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min in a shaking water bath.  After incubation in the genipin, specimens were transferred to PBS 124 
and incubated at 37ºC to bring the total incubation time to 24 h.30    125 
 126 
HISTOLOGY AND IMMUNOHISTOCHEMISTRY 127 
Alcian blue staining was performed to visualize cartilage damage and glycosaminoglycan 128 
(GAG) levels post-impact.  Specimens were impacted as described above and then incubated in 129 
PBS at 37°C for 24 h.  After incubation, the specimens were cut to 6 mm in length and were 130 
fixed in paraformaldehyde, decalcified in a formic acid solution, and embedded in OCT.  131 
Cryosections (7 µm) taken perpendicular to the cartilage surface were mounted to glass 132 
microscope slides, stained with Alcian Blue solution (Sigma Aldrich, St. Louis, MO) and 133 
counterstained with Nuclear Fast Red (Electron Microscopy Sciences, Hatfield, PA). Images 134 
were taken using an optical microscope (Nikon ME1600, Nikon Instruments Inc.; Melville, NY) 135 
connected to a digital camera (Optronics; Goleta, CA). 136 
Immunohistochemistry was performed to assess damaged collagen using antibody COL2-137 
3/4M, and collagenase cleavage using antibody COL2-3/4Cshort (both from Ibex Technologies, 138 
Inc, Mont-Royal, Canada).  COL2-3/4M nonspecifically targets an epitope within type 2 139 
collagen’s triple-helix which is exposed in the damaged molecule.  Since both mechanical 140 
overloading and collagenase cleavage can result in collagen damage, no distinction can be made 141 
between these two forms of damage with this antibody alone.  Therefore, COL2-3/4Cshort, which 142 
is specifically an indicator of collagenase cleavage, was used in conjunction with COL2-3/4M to 143 
visualize the damage that was exclusively due to mechanical disruption.  Immunohistochemistry 144 
using COL2-3/4M and COL2-3/4Cshort was performed on 7 µm cartilage cryosections that had 145 
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been removed from the subchondral bone.  The sections underwent a mild fixation in 95% 146 
ethanol before they were subjected to antigen retrieval with 0.5% hyaluronidase in PBS for 20 147 
minutes at 37°C.  Nonspecific binding sites and endogenous biotin were blocked at room 148 
temperature with goat serum, 0.01% Avidin (Pierce Biotechnology, Rockford, IL), and 0.001% 149 
Biotin (Sigma Aldrich).  Sections were then incubated in 1:400 dilutions of primary antibodies, 150 
either COL2-3/4M or COL2-3/4C short, for 1 h at 37°C.  Biotinylated secondary antibodies 151 
directed against the appropriate species (Vector Laboratories, Burlingame, CA; 1:100) were 152 
applied for 1 h at 37°C.  Only the secondary antibody was applied for the negative control.  153 
Sections were incubated in avidin-biotin complex according to the manufacturer’s instruction 154 
(Vectastain Elite ABC Kit; Vector Laboratories) and developed with DAB peroxidase (Vector 155 
Laboratories) for 10 min at 37°C.  Slides were rinsed between each step. 156 
 157 
SGAG RELEASE FROM IMPACTED SPECIMENS 158 
A modified dimethylmethylene blue (DMMB) assay was performed to determine the 159 
effect of the 24 h incubation on sulfated glycosaminoglycan (sGAG) loss from impacted and 160 
control specimens (n = 8). Osteochondral specimens were impacted then immediately incubated 161 
in 1 ml of PBS at 37°C for 24 hours, as in the 0 mM condition.  Specimens that were not 162 
impacted but were incubated in PBS at 37°C for 24 hours acted as controls.  Briefly, aliquots of 163 
the incubation solution were mixed with a dye solution consisting of 80 µM DMMB, 1% 164 
ethanol, 40 mM guanidine-HCl, 315 µM formic acid, and 25 µM sodium hydroxide at a pH of 165 
3.5 for 30 minutes and then centrifuged. The supernatant was removed and the remaining pellet 166 
was resuspended in a dissociation buffer of 10% isopropanol and 4 M guanidine-HCl. The 167 
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resultant solution was measured colorimetrically at 600 nm and the amount of sGAG was 168 
estimated from chondroitin sulfate standards. 169 
 170 
VISCOELASTIC PARAMETERS FROM INDENTATION 171 
Stress-relaxation tests were performed on separate 9.5 mm diameter osteochondral 172 
specimens with a Hysitron TI950 TriboIndenter (Minneapolis, MN) equipped with a 3-D 173 
OmniProbe® transducer and a 750 µm diameter flat punch probe with a 20 µm edge radius.35 174 
The load function consisted of a 20-second ramp to peak displacement, followed by a 50-second 175 
hold at peak displacement and a 1-second unloading segment. Testing was carried out with a 0.5 176 
mN preload followed by a 67 µm peak indentation depth.  This protocol was previously found to 177 
produce repeatable measurements of the unloading stiffness that were sensitive to changes due to 178 
crosslinking.36  Indentations were performed in quadruplicate at three locations selected at 179 
random on each specimen.  Immediately following indentation testing, the articular surface of 180 
the cartilage was impacted via drop tower, using the previously described protocol.  After impact 181 
the specimens underwent indentation again at the same locations.  Following the post-impact 182 
indentation testing, specimens were crosslinked in genipin, as described above, equilibrated in 183 
PBS at room temperature for an additional 2 h, and then indentation testing was repeated at the 184 
same three locations on four specimens per condition (n = 12).  The relaxation portion of the 185 
indentation stress relaxation data was analyzed with a standard linear solid model (SLS) as 186 
previous described.30 The changes in instantaneous stiffness, equilibrium stiffness, and relaxation 187 
time constant were reported.  The unloading stiffness was evaluated as the slope from a linear fit 188 
of the top 10% of the unloading curve.37  The unloading stiffness is directly proportional to the 189 
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elastic modulus of the tissue for a flat punch indenter.38  Values for each apparent parameter 190 
were normalized by the corresponding pre-impact value.  191 
COLLAGENASE DIGESTION 192 
In additional experiments, 9.5 mm diameter osteochondral specimens were impacted and 193 
then 5.9 mm diameter cylinders were cored from the center of the specimens such that the 194 
articular surface was perpendicular to the coring axis. The smaller diameter was used to ensure 195 
flatness of the articular surface so that uniform sections could be taken.  The specimens were cut 196 
to a length of 6 mm using an Isomet Low Speed Saw (Buehler, Lake Bluff, IL).  Specimens were 197 
incubated in 0, 2, or 10 mM solutions of genipin in PBS for 15 minutes and then in genipin-free 198 
PBS for the remaining 24 hours, as above (n = 4).  Specimens that were not impacted and were 199 
incubated in PBS for 24 h acted as controls.  Using a sledge microtome (HM 450 Richard Allan, 200 
Kalamazoo, MI) equipped with a freezing stage (Physitemp, Clifton, NJ) set at -25 ºC, 150 µm 201 
sections were taken through the depth of the articular cartilage as has previously been 202 
described.30  Individual sections were incubated for 45 minutes at 37 °C in 0.5 mL of a 2 mg/mL 203 
solution of type I collagenase from Clostridium histolyticum in 50 mM Trizma® buffer at pH 204 
7.42 containing 10 mM CaCl2 (all from Sigma Aldrich).  To quantify the collagen that had been 205 
digested, the samples of the digest solution were hydrolyzed at 100°C for 18 h in concentrated 206 
HCl (38%) and assessed for hydroxyproline with a chloromine-T assay.  Hydroxyproline is an 207 
amino acid constituent that is found almost exclusively in collagen.  As impact damage and 208 
subsequent wear occur primarily at the articular surface, the quantity of collagen that had been 209 
digested at the articular surface was reported in addition to data taken throughout depth of the 210 
tissue.  211 
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FRICTION AND WEAR TESTING 212 
Friction testing was conducted on 9.5 mm diameter osteochondral specimens that had 213 
been impacted then immediately incubated in either 0 or 10 mM genipin solution in PBS as 214 
described above.  Specimens that were not impacted and were incubated in 0 mM genipin acted 215 
as controls.  The coefficient of friction (COF) between cartilage and stainless steel (T316; Ra = 216 
0.016 ± 0.004 µm) was measured in a hydrating solution consisting of 0.15 M NaCl with 217 
protease inhibitors (1mM ethylenediaminetetraacetic acid, 5 mM benzamadine and  10 mM n-218 
ethylmaleimide).  To provide insight into the subsequent wear test, reciprocal sliding motion was 219 
carried out using a Universal Micro-Tribometer (Bruker, Inc., Campbell, CA) under a constant 220 
normal load of 70 N (approximately 1.6 MPa contact pressure, or greater than the average 221 
pressure in the knee but below measured peak pressures39) for 30 min at a sliding speed of 4 222 
mm/s, with each back and forth portion being 18 mm long (n = 4).  The friction and normal 223 
forces were averaged over each cycle of reciprocal motion, the COF was obtained from the ratio 224 
of these values, and the initial value from the first reciprocal cycle was reported.  Between tests, 225 
the stainless steel was thoroughly cleaned with 70% ethanol, followed by a distilled water rinse.   226 
To perform wear testing, specimens were impacted then crosslinked in 0, 2, or 10 mM 227 
genipin solutions.  Specimens that were not impacted and were incubated in 0 mM genipin 228 
served as controls.  Cartilage was worn against 316L stainless steel discs (Ra = 0.015 ± 0.002 229 
µm) as previously described (n = 6 per condition).40  Briefly, specimens were loaded into a pin-230 
on-disk tribometer (OrthoPOD from AMTI; Watertown, MA) with the hydrating fluid and tested 231 
in cycles consisting of four 18 mm strokes in a square path with a sliding velocity of 4 mm/s.  A 232 
load of 70 N was applied at a rate of 150 N/s and removed for the final 45% (~8 mm) of each 233 
stroke to permit specimen rehydration.  Testing was conducted at room temperature for a total of 234 
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9600 cycles and a wear distance of 384 m.  The load and cycle number were chosen based on 235 
preliminary studies that determined these conditions resulted in consistent wear on impacted, 236 
non-crosslinked specimens. 237 
To quantify cartilage wear, the amount of hydroxyproline that was released to the 238 
hydrating saline solution was assessed.  The hydrating baths were lyophilized, re-suspended in 239 
papain digest solution, and incubated at 60°C overnight.  Samples of the digest solution were 240 
hydrolyzed and assessed with a chloromine-T assay, as above.  Additionally, verification of wear 241 
was performed with India ink staining the articular surface; the areas that were stained after 242 
wiping the surface with a damp cloth indicated damage based on the adherence of India ink to 243 
fibrillated cartilage.40 244 
STATISTICS 245 
Differences between groups that had been impacted and treated with the different genipin 246 
concentrations were determined using a one-way ANOVA with Tukey’s post-hoc test with 247 
significance set at p<0.05 (Graphpad Prism Software, La Jolla, CA).  A one sample t-test was 248 
used to determine the difference of unloading stiffness, instantaneous stiffness, equilibrium 249 
stiffness and relaxation time constant normalized to corresponding initial values from 1.0.  A 250 
two-way ANOVA with Tukey post-hoc test was performed to determine the significance of the 251 
different groups and the cartilage depth on the amount of hydroxyproline released during 252 
collagenase digestion.  Data are presented as mean ± standard deviations. 253 
 254 
RESULTS 255 
IMPACT DAMAGE 256 
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The impact protocol resulted in a maximum contact pressure at peak displacement of 52.8 257 
± 17.0 MPa, with an average contact pressure of 35.2 ± 11.4 MPa at the same time point.  The 258 
average impact energy and velocity were 0.89 ± 0.30 J and 1.8 ± 0.35 m/s, respectively.  259 
Assuming that only the cartilage deformed, the maximum strains were 0.903 ± 0.312 and 0.723 ± 260 
0.250 for cartilage thicknesses of 1.2 and 1.5 mm, respectively, while the mean strain rates were 261 
1370 ± 580 and 1100 ± 460 s-1, respectively.  Alcian blue staining of impacted cartilage 262 
demonstrated fissure formation at the articular surface, but also revealed that proteoglycans 263 
(GAG) were retained by the bulk of the cartilage post-impact (Figure 1A).  264 
Immunohistochemistry indicated that collagen became damaged under the impact in the 265 
superficial zone (Figure 1B), while staining for collagenase cleavage was much fainter and more 266 
diffuse (Figure 1C).   Specimens that did not receive an impact did not show evidence of 267 
damaged collagen (Figure S2A), nor was non-specific binding observed (Figure S2B).  SGAG 268 
loss due to the 24 h incubation was 59.2 ± 38.7 and 93.8 ± 47.5 µg in the control and impacted 269 
specimens, respectively.  No significant differences were detected between the two groups (p = 270 
0.133). 271 
VISCOELASTIC PARAMETERS FROM INDENTATION 272 
The average instantaneous, equilibrium, and unloading stiffness all decreased with impact 273 
by 52.1, 47.6 and 40.2% respectively (Figure 2A-C) as compared to pre-impact values.  274 
Additionally, all the stiffness measurements decreased further for the untreated (0 mM genipin) 275 
specimens after the 24 hour incubation, with the equilibrium stiffness exhibiting the greatest 276 
change of 84%.  However, treatment with genipin reversed this effect of the impact.  At 2 mM, 277 
genipin treatment tended to restore the stiffness, and the 10 mM genipin treatment significantly 278 
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increased all stiffness measurements compared to the untreated (0 mM genipin) specimens.  The 279 
impact load did not affect the relaxation time constant, but crosslinking with either the 2 or 10 280 
mM genipin treatments caused a significant decrease (Figure 2D). 281 
 282 
COLLAGENASE DIGESTION 283 
There were no significant differences between the non-impacted and impacted 0 mM 284 
groups in the amount of hydroxyproline released to solution during collagenase digestion at any 285 
depth within the cartilage (Figure 3A).  Throughout the depth of the cartilage, treatment with 10 286 
mM genipin tended to decrease hydroxyproline released compared to the other treatment groups.  287 
In the surface cartilage sections, collagenase digestion was equivalent in both the non-impacted 288 
and impacted 0 mM genipin groups (Figure 3B).  The amount of digestion decreased in the 2 289 
mM genipin group in the surface sections, but only compared to the non-impacted controls.  290 
Treatment with 10 mM genipin significantly decreased collagenase digestion compared to both 291 
the non-impacted control and untreated (0 mM genipin) groups in the surface sections.     292 
 293 
FRICTION AND WEAR 294 
Impact loading did not alter the COF of the articular cartilage when loaded to 70 N.  295 
Treatment with 10 mM genipin after impact loading also had no effect on the COF (Figure 4).  296 
India ink staining suggested that impacted specimens sustained more wear than the non-impacted 297 
specimens in the absence of genipin treatment, but that wear was reduced by crosslinking the 298 
tissue in 2 and 10 mM genipin (Figure 5A).  Quantitative testing of wear confirmed that the 299 
impacted specimens without treatment released significantly more collagen during the wear test 300 
than those that had not been impacted, and that the 2 and 10 mM genipin crosslinking treatments 301 
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reduced the wear of the impacted specimens to levels that were comparable to that of the non-302 
impacted controls (Figure 5B).  303 
 304 
 305 
DISCUSSION 306 
This study investigated the effect of a single, blunt impact on the mechanical behavior 307 
and biochemical degradation of articular cartilage.  In addition, genipin crosslinking was 308 
investigated as a potential therapeutic treatment to slow the degeneration of impact-damaged 309 
cartilage and potentially the progression of PTOA.  The results indicate that the acute effects of 310 
an injurious impact load to articular cartilage leads to decreases in material stiffness but that 311 
treatment with genipin partially or fully restored the viscoelastic parameters of the tissue.  The 312 
wear resistance of impacted articular cartilage was also diminished compared to undamaged 313 
cartilage, suggesting that the mechanical damage that is directly induced by the impact may 314 
contribute to the development of PTOA.   However, the wear resistance of the damaged tissue 315 
was fully restored by the crosslinking treatments.  The crosslinking treatments also improved the 316 
resistance to collagenase digestion at the impact-damaged articular surface.  Taken together, 317 
these results demonstrate the potential therapeutic value of collagen crosslinking, and highlight 318 
genipin as a promising approach to the prevention of cartilage degeneration after traumatic 319 
injury. 320 
Impact loading significantly decreased all cartilage stiffness measurements. This is 321 
consistent with the fissure formation at the articular surface observed by histology and collagen 322 
network denaturation and microarchitectural damage in the superficial zone observed by 323 
immunohistochemistry.   Another factor may have been the 58.7% average increase in sGAGs 324 
released from the impacted specimens during the 24 h incubation, though the difference was not 325 
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significant.  Genipin treatment tended to restore the stiffness of the tissue up to a point.  326 
However, the restoration of stiffness by crosslinking was likely limited due to the formation of 327 
the fissures, which the crosslinking treatments were unable to repair.  Impact did not change the 328 
stress relaxation time constant, but it was decreased by both genipin crosslinking treatments, 329 
similar to what was seen previously with healthy, intact cartilage.30  It should be noted that the 330 
change in viscoelastic parameters were measured via 70 µm indentation and may not reflect the 331 
change in properties through the depth of the tissue. 332 
There was no significant difference in collagenase digestion between the non-impacted 333 
and impacted 0 mM genipin groups anywhere through the depth, indicating that the acute 334 
mechanical damage induced by impact does not lead to enhanced susceptibility of cartilage to 335 
collagenase.  Regardless, levels of degradative enzymes are elevated in joints after a trauma; a 336 
single impact load to cartilage causes an adverse cellular response, including an increased 337 
expression of pro-inflammatory cytokines such as interleukin-1 (IL-1),6 which are thought to 338 
activate degradative enzymes4 that reduce the mechanical properties of the cartilage over 339 
time.5,11  Weakening of the tissue through this catabolic pathway is one mechanism by which a 340 
traumatic injury progresses to PTOA.  A therapeutic treatment that protects cartilage from the 341 
degradative post-injury environment may slow the development of PTOA.  The present data 342 
indicate that crosslinking the cartilage in 2 mM genipin decreased collagenase digestion at the 343 
articular surface compared to healthy cartilage, while the tissue that received the 10 mM 344 
treatment was even more resistant to collagenase.  These results indicate that collagen 345 
crosslinking enhances the resistance to biochemical degradation at the articular surface of 346 
impact-damaged cartilage, and may preserve cartilage after trauma. 347 
16 
 
The increased wear observed in response to impaction injury is likely due to the 348 
microarchitectural damage and fissure formation that occurred at the articular surface and may 349 
contribute to the progression of PTOA.  The wear data show that the cartilage that had been 350 
damaged and then treated with either concentration of genipin did not did not differ from non-351 
impacted controls, indicating that both genipin treatments restored the wear resistance that was 352 
lost after the traumatic impact.  As crosslinking did not alter the COF, the improved wear 353 
resistance is likely due to strengthening of the tissue.   354 
Limitations of this study include the fact that it is difficult to directly compare the impact 355 
from the current study to those in whole joints. The impact load that was imparted by the drop 356 
tower is designed to mimic physiologic joint trauma from automobile accidents, sports injuries, 357 
or military combat injuries. This model successfully generates standardized, reproducible, 358 
cartilage damage, including cartilage fissures at the articular surface and microarchitectural 359 
damage, which are hallmarks of joint trauma.  Similarly, it is difficult to compare impact 360 
parameters such as peak stress and strain between experimental studies because of differences in 361 
specimen geometry and anatomic location.  Previous experimental work found that stresses 362 
above 20 to 30 MPa applied at strain rates of 500 to 1,000 s-1 are necessary to cause chondrocyte 363 
death and fissure formation,31 consistent with the loading applied here.  One estimation that we 364 
made in our analysis of the impact load was that only cartilage deformed during our impact 365 
protocol and not bone; although cartilage is much more compliant, the deformation would have 366 
been distributed to both tissues.  Another estimate was the thickness of the cartilage, which was 367 
assumed to be in the range of 1.2 to 1.5 mm, but was not directly measured.  The study was 368 
performed using approximately 1-year old, skeletally immature bovine tissue, and the measured 369 
results may not be indicative of those from cartilage with a mature morphology.  Finally, we note 370 
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that the specimens were frozen before use, and that the matrix of all the specimens would have 371 
been exposed to degradative enzymes from the ruptured cells.  A degraded matrix may respond 372 
differently to impact and crosslinking than healthy tissue, and future studies are planned to 373 
investigate whether crosslinking strengthens cartilage that has been enzymatically degraded as in 374 
the post-traumatic environment.  375 
Current treatments to prevent the development of PTOA aim to improve joint instability 376 
or incongruity,2,18–22 and are necessary to restore normal joint function.  Recent studies have 377 
investigated biological treatments that impair aspects of the post-trauma cellular response.23–29,41  378 
These treatments aim to decrease the risk of OA after an injury by limiting damage to the 379 
chondrocytes.  However, none of these therapies address the diminished material properties of 380 
the damaged cartilage tissue, or protect the articular surface from subsequent mechanical wear or 381 
biochemical degradation. The results of this study suggest that a collagen crosslinking agent such 382 
as genipin may be of therapeutic value either independently or as a complement to therapies that 383 
alter cell behavior.  In this study, the beneficial effects of genipin were observed even at the 384 
lower concentration of 2 mM.  Previous research has demonstrated that this genipin crosslinking 385 
treatment is non-toxic to chondrocytes, though toxicity is observed at higher concentrations.30  386 
Genipin treatments may be ideal for clinical applications where the joint is open, as intra-387 
articular injection would crosslink all the tissues of the joint, including the ligaments and 388 
synovium.  Alternately, it may be possible to devise a method to deliver genipin locally via an 389 
arthroscopic instrument that includes a genipin-soaked sponge and joint distension with gas 390 
rather than fluid.  Further experimental work will be necessary to assess the safety and efficacy 391 
of genipin in vivo, as well as to determine how to best achieve the potential benefits of collagen 392 
crosslinking as a treatment for PTOA. 393 
18 
 
 394 
ACKNOWLEDGEMENTS 395 
We thank Huseyin Arman for performing a portion of the immunohistochemistry in this study.  396 
The research was supported by the US Army Medical Research & Materiel Command 397 
W81XWH-07-066 (DRW and TCO)  and the Wendell F. Bueche Fellowship in Engineering 398 
(MEM), NIH grant AR047702 (SBT) and Department of Veterans’ Affairs merit award 399 
BX000447(SBT).  This publication was made possible in part by grants 1563721 from the NSF 400 
and AR069657 from the NIH (DRW).  The authors have no interests which might be perceived 401 
as posing a conflict or bias. 402 
 403 
FIGURE AND TABLE CAPTIONS 404 
Figure 1: Histology (A) and immunohistochemistry (B, C) of articular cartilage after a single 405 
impact.  A)  Alcian blue staining.  B)  Damaged collagen.  C) Collagenase-cleaved collagen.  406 
Scale bar = 200 µm. 407 
Figure 2: Viscoelastic parameters of articular cartilage.  Indentation testing was performed pre-408 
impact, immediately after single impact, and after treatment with the designated concentrations 409 
of genipin, all at the same locations of the cartilage surface.  A) Instantaneous stiffness; B) 410 
Equilibrium stiffness; C) Unloading stiffness; D) Relaxation time constant.  Data represent the 411 
mean ± SD of ratio to pre-impact data.  ** and ***: different from 1.0 (**:p<0.01, ***p<0.001). 412 
Different letters indicate statistical significance between groups (p<0.05).   413 
Figure 3: Hydroxyproline released by collagenase digestion.  Articular cartilage was either un-414 
injured (No Impact), or subjected to a single impact.  Specimens were then treated with the 415 
designated concentrations of genipin and sliced into 150µm sections starting at the cartilage 416 
19 
 
surface.  A) Hydroxyproline released from 150 µm thick sections from the designated cartilage 417 
depth.  B) Hydroxyproline released from the surface section of the cartilage.  Data is a subset of 418 
data in A (150 on x-axis).  Data represent mean ± SD of hydroxyproline content per section. 419 
Different letters indicate statistical significance between groups (p<0.05). 420 
Figure 4:  Top:  Representative coefficient of friction (COF) over the 30 minute test.  Bottom:  421 
The initial COF of articular cartilage surfaces. Articular cartilage was either un-injured (No 422 
Impact), or subjected to a single impact.  Specimens were then treated with the designated 423 
concentrations of genipin before COF measurement. Data represent mean ± SD of COF. 424 
Figure 5: Wear testing of articular cartilage. A) India ink staining of articular cartilage subjected 425 
to the designated impact and genipin treatments.  Images were obtained before and after wear 426 
testing and represent the maximum wear for each condition.  B) Hydroxyproline released from 427 
articular cartilage during wear testing following the designated impact and genipin treatments.  428 
Data represent mean ± SD of hydroxyproline content per sample.  (*:p<0.05, **:p<0.01). 429 
Figure S1:  A custom built drop tower applied an impact load in unconfined compression to 430 
cartilage-bone specimens. 431 
Figure S2:  Immunohistochemistry of A) healthy articular cartilage stained for damaged 432 
collagen, and B) a negative control for damaged collagen.  433 
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